Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,146 public trials 2,034 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Recruiting

Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning

NCT03852407

Conditions: Acute Lymphoid Leukemia in Remission, Acute Myeloid Leukemia in Remission, Blood Protein Disorders, +33 more
Locations: ZNA Stuivenberg Antwerp, Belgium

AZ Sint Jan Brugge Bruges, Belgium

IJ Bordet Brussels, Belgium

UZ Brussel Brussels, Belgium

View Trial Details

Recruiting

PUMCH Dementia Longitudinal Cohort Study

NCT05023564

Conditions: Alzheimer Disease, Arterial Occlusive Diseases, Arteriosclerosis, +36 more
Locations: Peking Union Medical College Hospital Beijing, China

View Trial Details

Recruiting

A Study to Investigate the Safety and Tolerability of SCR-6920 Capsule in Patients With Advanced Malignant Tumors

NCT05528055

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Shandong Cancer Hospital Jinan, Shandong, China

View Trial Details

Recruiting

B-cell Mature Non-Hodgkin's Lymphoma Treatment Protocol in Children and Adolescents 2021

NCT05518383

Conditions: Burkitt Lymphoma, DNA Virus Infections, Diffuse Large B-cell Lymphoma, +19 more
Locations: Dmitry Rogachev National Medical Research Center Of Pediatric Hematology, Oncology and Immunology Moscow, RF, Russia

View Trial Details

Recruiting

Prephase Treatment With Prednisone +/- Vitamin D Supplementation Followed by Immunochemotherapy

NCT04442412

Conditions: Diffuse Large B-cell Lymphoma, Elderly Patients, Hemic and Lymphatic Diseases, +10 more
Locations: SC Ematologia Spedali Civili Brescia, BS, Italy

UO Ematologia e CTMO di Piacenza Piacenza, PC, Italy

Ospedale Oncologico regionale CROB Rionero in Vulture, Piacenza, Italy

A.O. SS. Antonio e Biagio e Cesare Arrigo - S.C. Ematologia Alessandria, Italy

View all 49 locations

View Trial Details

Recruiting

Allogeneic Stem Cell Transplantation in Relapsed/Refractory T-, NK/T-cell Lymphomas

NCT02859402

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: Dong-A University Busan, South Korea

Keimyung University Dongsan Medical Center Daegu, South Korea

View Trial Details

Recruiting

Human CD19 Targeted T Cells Injection(CD19 CAR-T) Therapy for Relapsed and Refractory B-cell Non-Hodgkin's Lymphoma

NCT05436223

Conditions: B-cell Non-Hodgkin's Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +12 more
Locations: Zhongshan Hospital, Fudan University Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Safety, Tolerability, and Efficacy of AT101 in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma

NCT05338931

Conditions: B-cell Non Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Asan Medical Center Seoul, South Korea

View Trial Details

Recruiting

APRIL CAR-T Cell Therapy for Patients With BCMA/TACI Positive Relapsed and/or Refractory Multiple Myeloma

NCT04657861

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: The First Affiliated Hospital，College of Medicine, Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Recruiting

Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma

NCT03161223

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: University of Virginia Charlottesville, Virginia, United States

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions